Jacobs & Co’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.15M | Sell |
21,959
-2,158
| -9% | -$567K | 0.53% | 60 |
|
|
2026
Q1 | $6.43M | Buy |
24,117
+511
| +2% | +$138K | 0.64% | 58 |
|
|
2025
Q4 | $5.92M | Sell |
23,606
-593
| -2% | -$157K | 0.56% | 62 |
|
|
2025
Q3 | $6.95M | Sell |
24,199
-353
| -1% | -$94.6K | 0.66% | 59 |
|
|
2025
Q2 | $6.45M | Sell |
24,552
-416
| -2% | -$101K | 0.64% | 60 |
|
|
2025
Q1 | $5.81M | Sell |
24,968
-345
| -1% | -$83.7K | 0.62% | 65 |
|
|
2024
Q4 | $5.8M | Buy |
25,313
+120
| +0.5% | +$27.5K | 0.59% | 64 |
|
|
2024
Q3 | $5.63M | Buy |
25,193
+550
| +2% | +$121K | 0.56% | 68 |
|
|
2024
Q2 | $5.01M | Buy |
24,643
+1,013
| +4% | +$206K | 0.53% | 69 |
|
|
2024
Q1 | $5.16M | Buy |
23,630
+424
| +2% | +$93.4K | 0.55% | 68 |
|
|
2023
Q4 | $5.27M | Hold |
23,206
| – | – | 0.6% | 62 |
|
|
2023
Q3 | $4.67M | Sell |
23,206
-3,806
| -14% | -$803K | 0.58% | 66 |
|
|
2023
Q2 | $5.6M | Sell |
27,012
-698
| -3% | -$135K | 0.67% | 59 |
|
|
2023
Q1 | $5.46M | Sell |
27,710
-823
| -3% | -$169K | 0.67% | 64 |
|
|
2022
Q4 | $5.77M | Sell |
28,533
-47
| -0.2% | -$9.19K | 0.75% | 58 |
|
|
2022
Q3 | $5.03M | Sell |
28,580
-134
| -0.5% | -$27.4K | 0.72% | 58 |
|
|
2022
Q2 | $5.78M | Sell |
28,714
-2,262
| -7% | -$482K | 0.77% | 58 |
|
|
2022
Q1 | $7.02M | Sell |
30,976
-187
| -0.6% | -$44K | 0.78% | 58 |
|
|
2021
Q4 | $8.41M | Sell |
31,163
-399
| -1% | -$98.8K | 0.87% | 53 |
|
|
2021
Q3 | $7.63M | Buy |
31,562
+338
| +1% | +$85.2K | 0.88% | 52 |
|
|
2021
Q2 | $7.4M | Sell |
31,224
-454
| -1% | -$103K | 0.85% | 52 |
|
|
2021
Q1 | $6.94M | Sell |
31,678
-417
| -1% | -$83.7K | 0.85% | 53 |
|
|
2020
Q4 | $5.61M | Sell |
32,095
-61
| -0.2% | -$10.5K | 0.73% | 57 |
|
|
2020
Q3 | $5.2M | Buy |
32,156
+47
| +0.1% | +$7.45K | 0.75% | 57 |
|
|
2020
Q2 | $4.58M | Buy |
32,109
+768
| +2% | +$106K | 0.75% | 56 |
|
|
2020
Q1 | $3.4M | Sell |
31,341
-2,342
| -7% | -$337K | 0.66% | 60 |
|
|
2019
Q4 | $4.89M | Buy |
33,683
+1,379
| +4% | +$199K | 0.74% | 58 |
|
|
2019
Q3 | $4.66M | Sell |
32,304
-239
| -0.7% | -$34.9K | 0.76% | 53 |
|
|
2019
Q2 | $4.83M | Buy |
32,543
+1,129
| +4% | +$158K | 0.78% | 51 |
|
|
2019
Q1 | $4.13M | Buy |
31,414
+1,135
| +4% | +$140K | 0.7% | 57 |
|
|
2018
Q4 | $3.29M | Buy |
30,279
+1,636
| +6% | +$219K | 0.65% | 59 |
|
|
2018
Q3 | $4.27M | Buy |
28,643
+1,215
| +4% | +$185K | 0.72% | 54 |
|
|
2018
Q2 | $4.23M | Buy |
27,428
+375
| +1% | +$56.6K | 0.77% | 51 |
|
|
2018
Q1 | $3.76M | Sell |
27,053
-172
| -0.6% | -$25.3K | 0.69% | 57 |
|
|
2017
Q4 | $3.68M | Buy |
27,225
+1,707
| +7% | +$226K | 0.66% | 61 |
|
|
2017
Q3 | $3.31M | Buy |
25,518
+1,523
| +6% | +$203K | 0.62% | 66 |
|
|
2017
Q2 | $3.18M | Buy |
23,995
+2,140
| +10% | +$262K | 0.63% | 68 |
|
|
2017
Q1 | $2.69M | Buy |
21,855
+640
| +3% | +$75.8K | 0.55% | 71 |
|
|
2016
Q4 | $2.34M | Buy |
21,215
+3,885
| +22% | +$432K | 0.51% | 75 |
|
|
2016
Q3 | $2.05M | Buy |
17,330
+542
| +3% | +$63.9K | 0.46% | 77 |
|
|
2016
Q2 | $1.88M | Buy |
16,788
+1,175
| +8% | +$126K | 0.44% | 72 |
|
|
2016
Q1 | $1.57M | Buy |
15,613
+1,711
| +12% | +$164K | 0.38% | 79 |
|
|
2015
Q4 | $1.37M | Buy |
13,902
+4,924
| +55% | +$508K | 0.36% | 80 |
|
|
2015
Q3 | $836K | Buy |
+8,978
| New | +$929K | 0.22% | 97 |
|
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
Jacobs & Co's LH Position: Q2 2026 in Review
Jacobs & Co reduced its Labcorp (LH) stake by 8.9% in Q2 2026, selling an estimated $567K and leaving 21,959 shares worth $6.15M. The position accounts for 0.53% of the portfolio, ranked #60.
Jacobs & Co first reported a position in LH in Q3 2015 and has held it in 44 quarters since. The position peaked at $8.41M in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Jacobs & Co held 21,959 shares of Labcorp worth $6.15M as of Q2 2026.
- Jacobs & Co sold 2,158 Labcorp shares in Q2 2026, an estimated $567K.
- Labcorp made up 0.53% of Jacobs & Co's portfolio in Q2 2026, its #60 holding.
- Jacobs & Co first reported a position in Labcorp in Q3 2015 and has held it in 44 quarters since.
- Jacobs & Co's Labcorp position peaked at $8.41M in Q4 2021.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.